Foli Bio Inc.
New York, NY
- UEI
- MXWVDZNBK5L1
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 4080 Broadway #247, New York, NY 10032, USA
- Website
- foli.bio
- Founded
- 2023
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i: development of a high-throughput fecal exfoliome analyzing platform for clinical drug development -the… | National Science Foundation | $305,000 | |
| Non-invasive exfoliome platform to accelerate treatment for gastrointestinal disorders - summary inflammatory bowel… | National Institute of Diabetes and Digestive and Kidney Diseases | $584,750 |
Quick answers
What is Foli Bio Inc.'s UEI?
Foli Bio Inc.'s Unique Entity ID (UEI) in SAM.gov is MXWVDZNBK5L1.
Where is Foli Bio Inc. located?
Foli Bio Inc.'s physical address in SAM.gov is 4080 Broadway #247, New York, NY 10032, USA.
Is Foli Bio Inc. registered in SAM.gov?
Yes. Foli Bio Inc.'s SAM.gov registration is active through September 24, 2027.
What is Foli Bio Inc.'s most recent federal award?
Foli Bio Inc.'s most recent federal grant award is Sbir phase i: development of a high-throughput fecal exfoliome analyzing platform for clinical drug development -the… (2528222), from National Science Foundation, on October 1, 2025.
On GovTribe
See Foli Bio Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors